These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15515615)

  • 1. Minimally invasive esophagectomy.
    Gilbert S; Luketich JD
    Adv Surg; 2004; 38():67-83. PubMed ID: 15515615
    [No Abstract]   [Full Text] [Related]  

  • 2. The sweet approach is still worthwhile in modern esophagectomy.
    Ma J; Zhan C; Wang L; Jiang W; Zhang Y; Shi Y; Wang Q
    Ann Thorac Surg; 2014 May; 97(5):1728-33. PubMed ID: 24650587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramucosal esophageal cancer and high-grade dysplasia: which treatment frame the debate.
    Oelschlager BK
    J Gastrointest Surg; 2009 Jul; 13(7):1169-71. PubMed ID: 19322615
    [No Abstract]   [Full Text] [Related]  

  • 4. Robotic esophagectomy: is it an advance and what is the future?
    Watson TJ
    Ann Thorac Surg; 2008 Feb; 85(2):S757-9. PubMed ID: 18222211
    [No Abstract]   [Full Text] [Related]  

  • 5. The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center.
    Schwameis K; Ba-Ssalamah A; Wrba F; Birner P; Prager G; Hejna M; Schmid R; Asari R; Zacherl J; Schoppmann SF
    Anticancer Res; 2013 May; 33(5):2085-91. PubMed ID: 23645759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Short-term outcomes of minimally invasive Sweet esophagectomy for Siewert type Ⅱ esophagogastric junction adenocarcinoma].
    Liu CQ; Xie MR; Guo MF; Sun XH; Wu HR; Sun XX; Xu MQ
    Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):461-465. PubMed ID: 27938582
    [No Abstract]   [Full Text] [Related]  

  • 7. [Selective use of transhiatal esophagectomy for esophageal cancer].
    Haeder L; Jähne J
    Chirurg; 2012 Jul; 83(7):669. PubMed ID: 22782176
    [No Abstract]   [Full Text] [Related]  

  • 8. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
    DeMeester SR
    Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
    [No Abstract]   [Full Text] [Related]  

  • 9. [MINIMALLY INVASIVE ESOPHAGECTOMY].
    Levchenko EV; Khandogin NV; Karachun AM; Shcherbakov AM; Dvoretsky SY; Radzhabova ZA; Komarov IV; Ivashikin YM; Armasheva MV; Barchuk AS; Gorokhov LV
    Vopr Onkol; 2015; 61(3):376-80. PubMed ID: 26242148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
    Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
    Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive esophagectomy provides equivalent oncologic outcomes to open esophagectomy for locally advanced (stage II or III) esophageal carcinoma.
    Singh RK; Pham TH; Diggs BS; Perkins S; Hunter JG
    Arch Surg; 2011 Jun; 146(6):711-4. PubMed ID: 21690448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic Management of Early Upper Gastrointestinal Bleeding After Minimally Invasive Ivor-Lewis Esophagectomy.
    Zhang RQ; Kang NN; Che Y; Xia WL; Yu ZC; Pan HG; Ge W; Chen AG; Wan J
    Ann Thorac Surg; 2016 Apr; 101(4):1581-4. PubMed ID: 27000582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma.
    Zahoor H; Luketich JD; Levy RM; Awais O; Winger DG; Gibson MK; Nason KS
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):538-47. PubMed ID: 25454907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive esophagectomy.
    Dziodzio T; Kröll D; Denecke C; Öllinger R; Pratschke J; Biebl M
    Multimed Man Cardiothorac Surg; 2021 Apr; 2021():. PubMed ID: 33914420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection for esophageal cancer: strategies for optimal management.
    Pennathur A; Luketich JD
    Ann Thorac Surg; 2008 Feb; 85(2):S751-6. PubMed ID: 18222210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SSAT controversies intramucosal esophageal cancer and high-grade dysplasia: which treatment? Surgical therapy: improved outcomes and piece of mind.
    Peters JH
    J Gastrointest Surg; 2009 Jul; 13(7):1179-81. PubMed ID: 19294473
    [No Abstract]   [Full Text] [Related]  

  • 18. Short-term outcomes of minimally invasive Ivor-Lewis esophagectomy for esophageal cancer.
    Xie MR; Liu CQ; Guo MF; Mei XY; Sun XH; Xu MQ
    Ann Thorac Surg; 2014 May; 97(5):1721-7. PubMed ID: 24657031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dilemma of T1 esophageal adenocarcinoma.
    Molena D; DeMeester SR
    J Thorac Cardiovasc Surg; 2017 May; 153(5):1206-1207. PubMed ID: 28314532
    [No Abstract]   [Full Text] [Related]  

  • 20. [The road to modern esophageal surgery - from maximally invasive to minimally invasive].
    von Holzen U
    Praxis (Bern 1994); 2014 Aug; 103(16):955-60. PubMed ID: 25097164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.